149 related articles for article (PubMed ID: 3390376)
21. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
22. [Bone marrow biopsy using a Jamshidi needle in patients with malignant proliferative diseases of the lymphatic system].
Mioduszewska O
Patol Pol; 1987; 38(3-4):222-32. PubMed ID: 3444678
[No Abstract] [Full Text] [Related]
23. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
[TBL] [Abstract][Full Text] [Related]
24. A review of histology of bone marrow trephine in malignant lymphomas.
Durosinmi MA; Mabayoje VO; Akinola NO
Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
[TBL] [Abstract][Full Text] [Related]
25. [Bone marrow biopsy in the staging of malignant lymphoma].
Cohen Y; Vider S; Menster J; Ben-Arie J
Harefuah; 1978 May; 94(9):273-4. PubMed ID: 580929
[No Abstract] [Full Text] [Related]
26. [The significance of bone marrow and liver puncture in malignant lymphomas].
Güller R; Senn HJ; Nagel GA; Gudat F; Gyr K
Schweiz Med Wochenschr; 1972 Mar; 102(10):318-23. PubMed ID: 4113779
[No Abstract] [Full Text] [Related]
27. Bone marrow manifestations of malignant lymphoma and lymphoma-like conditions.
Brunning RD; McKenna RW
Pathol Annu; 1979; 14 Pt 1():1-59. PubMed ID: 390475
[No Abstract] [Full Text] [Related]
28. Bone marrow in malignant lymphoma.
McKenna RW; Hernandez JA
Hematol Oncol Clin North Am; 1988 Dec; 2(4):617-35. PubMed ID: 3065322
[TBL] [Abstract][Full Text] [Related]
29. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
Liu EB; Chen HS
Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
[TBL] [Abstract][Full Text] [Related]
30. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Eur J Haematol; 2015 Jul; 95(1):83-9. PubMed ID: 25537478
[TBL] [Abstract][Full Text] [Related]
31. Immunologic studies in malignant lymphoma. Correlation with histologic and bone-marrow changes.
Srichaikul T; Siriasawakul T; Wibulyachainunt S; Khantanaphar S; Matangkasombut P; Sirisinha S; Charupatana C
Am J Clin Pathol; 1974 Sep; 62(3):335-41. PubMed ID: 4606647
[No Abstract] [Full Text] [Related]
32. Frequency And Pattern Of Bone Marrow Involvement Among Patients With Non Hodgkin Lymphoma.
Zahur U; Zafar L; Khaliq S; Rehan M; Khalid A
J Ayub Med Coll Abbottabad; 2016; 28(3):497-500. PubMed ID: 28712221
[TBL] [Abstract][Full Text] [Related]
33. Detection of a systemic effect of malignancy in vivo by magnetic resonance imaging.
Richards MA; Gregory WM; Webb JA
Magn Reson Imaging; 1988; 6(5):557-65. PubMed ID: 3226239
[TBL] [Abstract][Full Text] [Related]
34. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow trephine biopsy in lymphoproliferative disease.
Schmid C; Isaacson PG
J Clin Pathol; 1992 Sep; 45(9):745-50. PubMed ID: 1401199
[No Abstract] [Full Text] [Related]
36. Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma.
Ozgüroglu M; Esen Ersavasti G; Demir G; Aki H; Demirelli F; Kanberoglu K; Mandel N; Büyükünal E; Serdengeçti S; Berkarda B
Pathol Oncol Res; 1999; 5(2):123-8. PubMed ID: 10393364
[TBL] [Abstract][Full Text] [Related]
37. Electron Microscopic investigations on sections from lymph nodes and bone marrow in malignant blood diseases.
BRAUNSTEINER H; FELLINGER K; PAKESCH F
Blood; 1957 Mar; 12(3):278-94. PubMed ID: 13403990
[No Abstract] [Full Text] [Related]
38. The superiority of histologic sections of aspirated bone marrow in malignant lymphomas. A review of 1,124 examinations.
Liao KT
Cancer; 1971 Mar; 27(3):618-28. PubMed ID: 5107906
[No Abstract] [Full Text] [Related]
39. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
[TBL] [Abstract][Full Text] [Related]
40. Quantitative magnetic resonance studies of lumbar vertebral marrow in patients with refractory or relapsed Hodgkin's disease.
Smith SR; Williams CE; Edwards RH; Davies JM
Ann Oncol; 1991 Feb; 2 Suppl 2():39-42. PubMed ID: 2049319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
